AARD · Aardvark Therapeutics Inc
United States · RS rating 2 · As of 2026-11-03
| Price | 1.23 USD |
|---|---|
| 1-day change | +2.5% |
| RS rating (overall / 1M / 3M / 12M) | 2 / 2 / 2 / 6 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 21 / 2 / 15 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -8.0% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +92.2% |
| Market cap (USD) | $117.2M |